Companies Cryptocurrencies
BridgeBio Pharma Inc
BridgeBio Pharma Inc
Exchange: NasdaqGS
IPO Date: 27/06/2019
CEO: Dr. Neil Kumar
Biotechnology Healthcare 🔗
  • BBIO
  • 45.4
  • 6799330816
    market cap
  • -1.7699966
If you bought

shares of BridgeBio Pharma Inc (BBIO) on
You would have made
Old Price $12 Current Price $12

BridgeBio Pharma, Inc. is a pharma company. The company is headquartered in Palo Alto, California and currently employs 185 full-time employees. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage development. The Company’s products include BBP-265, BBP-831, BBP-631 and BBP-454.

Address: 421 Kipling St Palo Alto CALIFORNIA 94301

Stay updated.